GTBPGT Biopharma, Inc.
0.2886USD+0.59%Mkt Cap: 13.02M $P/E: 0.063d ago
GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Enga…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap13.02M $
Enterprise Value7.76M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-28.35M $
Revenue/Share—
Last Price0.2886 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.06
P/E (Forward)-0.03
PEG1.05
EV/EBITDA—
EV/Revenue—
P/S—
P/B3.52
EPS (TTM)5.05
EPS (Forward)-10.80
52W Range
0.26102% of range1.526
52W High1.526 USD
52W Low0.2610 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-489.96%
ROA-349.79%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.91M $
CapEx (TTM)—
FCF Margin—
FCF Yield-68.80%
Net Debt-4.96M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio2.61
Quick Ratio2.23
Book Value/Sh0.0800 USD
Cash/Share0.1100 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 21, 2017
Splits
Last Split1:30
Split DateFeb 5, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.000 USD
Upside (mean)+939.5%
Target Range3.000 USD – 3.000 USD
# Analysts1
Ownership
Shares Out.45.11M
Float41.86M
Insiders5.71%
Institutions4.70%
Short Interest
Short Ratio4.6d
Short % Float10.87%
Short % Out.10.87%
Shares Short3.92M
Short (prev mo.)3.42M
Technical
SMA 500.3799 (-24.0%)
SMA 2000.5015 (-42.4%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)599.61K
Avg Vol (10d)471.91K
Technical Indicators
RSI (14)37.1
MACD-0.0243
MACD Signal-0.0258
MACD Hist.+0.0015
BB Upper0.3394 USD
BB Middle0.3088 USD
BB Lower0.2782 USD
BB Width19.79%
ATR (14)0.0260 USD
Vol Ratio (20d)0.56x